GE Healthcare Technologies Inc
NASDAQ:GEHC

Watchlist Manager
GE Healthcare Technologies Inc Logo
GE Healthcare Technologies Inc
NASDAQ:GEHC
Watchlist
Price: 79.08 USD -0.25%
Market Cap: 36.1B USD
Have any thoughts about
GE Healthcare Technologies Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one GEHC stock under the Base Case scenario is 108.67 USD. Compared to the current market price of 79.08 USD, GE Healthcare Technologies Inc is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GEHC Relative Value
Base Case
108.67 USD
Undervaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
38
vs Industry
51
Median 3Y
1.8
Median 5Y
1.8
Industry
2.3
Forward
1.8
More Details
21.6
P/E
P/E
Price to Earnings
21.6
vs History
50
vs Industry
24
Median 3Y
21.7
Median 5Y
21.7
Industry
23.1
Forward
18.1
More Details
17.3
P/OCF
P/OCF
Price to OCF
17.3
vs History
38
vs Industry
22
Median 3Y
16.9
Median 5Y
16.9
Industry
14.2
More Details
25.5
P/FCFE
P/FCFE
Price to FCFE
25.5
vs History
34
vs Industry
7
Median 3Y
8.6
Median 5Y
8.6
Industry
20.1
More Details
4.3
P/B
P/B
Price to Book Value
4.3
vs History
76
vs Industry
17
Median 3Y
4.8
Median 5Y
4.8
Industry
2.2
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
38
vs Industry
47
Median 3Y
2.1
Median 5Y
2.1
Industry
2.4
Forward
2.1
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
57
vs Industry
41
Median 3Y
5.2
Median 5Y
5.2
Industry
5
More Details
13.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.5
vs History
42
vs Industry
25
Median 3Y
13.4
Median 5Y
13.4
Industry
12.7
Forward
11.1
More Details
16.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.7
vs History
50
vs Industry
26
Median 3Y
16.6
Median 5Y
16.6
Industry
17.1
Forward
13.3
More Details
20.1
EV/OCF
EV/OCF
Enterprise Value to OCF
20.1
vs History
46
vs Industry
20
Median 3Y
19.7
Median 5Y
19.7
Industry
14
More Details
24.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.7
vs History
46
vs Industry
19
Median 3Y
24.2
Median 5Y
24.2
Industry
18
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
65
vs Industry
44
Median 3Y
1.6
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

GEHC Competitors Multiples
GE Healthcare Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD 1.8 21.6 13.5 16.7
US
Abbott Laboratories
NYSE:ABT
198.3B USD 4.8 34.3 20 29.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD 24.1 84.5 72 89.3
US
Stryker Corp
NYSE:SYK
140.4B USD 6.4 39.1 25.4 30.8
US
Boston Scientific Corp
NYSE:BSX
132.3B USD 8.4 74.2 33.9 48.4
IE
Medtronic PLC
NYSE:MDT
104.2B USD 3.2 24.3 13.5 19.2
US
Becton Dickinson and Co
NYSE:BDX
65.2B USD 3.2 37.6 15.7 28
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD 7.8 10.6 23.6 25.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
309.1B CNY 8.3 25 21.7 21.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34B USD 8.8 39.3 31 31

See Also

Summary
GEHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
GEHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GEHC stock valuation using valuation multiples.
Wall Street Estimates
GEHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GEHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.